A randomised trial of epirubicin versus mitomycin C at the time of first recurrence in superficial bladder cancer

INTERVENTION: First randomisation is between irrigation of the bladder with glycine/saline and no irrigation. The second randomisation is between Epodye and mitomycin C. CONDITION: Bladder cancer ; Cancer ; Bladder cancer PRIMARY OUTCOME: Local recurrence, time to progression, metastases, morbidity SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: 1. Newly‐diagnosed superficial carcinoma of bladder suitable for complete endoscopic resection, limited to the bladder 2. World Health Organisation (WHO) status zero to two 3. Expected survival at least three years 4. No history of other malignant tumours, except non‐melanomatous skin tumours, or carcinoma in‐situ (CIN) 5. No untreated urinary tract infection (UTI)